How to Move Pharma Clinical Translation to AI Translation With Human Review
Moving a pharma clinical trial off a legacy machine translation engine onto AI translation takes six steps, and the order is the whole job. Get it wrong and an informed consent form reads fluently while a dosing instruction drifts. Get it right and you keep the same regulatory record a fully human team would give you, at a fraction of the turnaround.
AD VERBUM is an EU-hosted AI translation company that runs clinical trial documents through a client-tuned LLM constrained by your translation memory and term base, then certified linguist review under ISO 17100 and ISO 18587, with no public-cloud transit and no training on client data. Here's the AI-powered translation workflow we run for clinical operations and regulatory teams, step by step, so you can set up the same one.
Settle one thing first. No EMA rule and no ICH guideline names an AI translation tool or bans one. What an inspector reads is whether your essential records are accurate and whether a qualified person signed for them. That's a question about your review trail, not your model.
What changes when you leave a legacy engine
A legacy neural machine translation engine was tuned once, processes one segment at a time, and keeps no memory of the sentence before. For a package leaflet or an informed consent form, that segment-level view is where meaning slips. A client-tuned large language model reads the whole document, holds context, and when you bind it to your approved terminology it stops guessing at the terms that carry risk.
The record side has moved too. ICH E6(R3) renamed essential documents to essential records and expects the trial master file to show how each one was produced and checked. Its Principles and Annex 1 have applied since 23 July 2025, and Annex 2 takes effect on 15 January 2027. A translation you can't account for is a gap in that file.
How to move pharma clinical translation to AI translation
Six steps, in sequence. Each one feeds the next, so the early steps decide what the late ones cost you.
Lock your translation memory and term base. Pull approved wording from past accepted trials, protocol terms, endpoint names, and standard consent phrasing, into a term base, and load your translation memory so earlier sign-offs carry forward instead of being retranslated from scratch.
Select an EU-hostable open-weight model. Choose a model you can run on your own EU infrastructure rather than a public API, so controlled clinical data never leaves servers you control. Open-weight models you can self-host make this the default, not the exception.
Constrain generation to your terminology. Feed the term base and memory to the model so it produces output bound to your approved terms, not free-form fluent text. Constrained generation is what separates AI translation from a raw machine pass.
Apply certified post-editing under ISO 18587. A qualified clinical linguist edits the output and takes named responsibility for the final text, the same bar a fully human workflow meets.
Record the review trail. Log who reviewed what, against which term base version, and file it where the trial master file can reach it. This is the record ICH E6(R3) and the EU AI Act both expect.
Keep client data out of training. Confirm in writing that your source files, memory, and output are never used to train a shared model, and that the whole path stays on EU-hosted infrastructure.
Notice the model sits in the middle, not at the end. The last word on a clinical document belongs to a person who signs for it.
Lock your memory and terminology first
This is the step teams skip when they're in a hurry, and it's the one that decides quality. A clinical term base fixes how an adverse event, a dosing instruction, or an endpoint appears every time, so the model can't paraphrase a defined term into something a reviewer has to catch later. Build it from documents a regulator has already accepted, not from a fresh glossary written for this project. If you want the fuller picture of why constrained generation plus certified review is what we mean by the term, we set it out in what AI translation means for regulated content.
Certified post-editing is the step regulators inspect
ISO 18587 is the standard for full post-editing of machine and model output, and it puts a named, qualified post-editor on the hook for the final translation. Its 2026 revision, out for enquiry until November, widens the scope to cover output from AI and large language models directly. Pair it with ISO 17100, the translation-process standard that requires an independent reviser, and the edit stops being a courtesy pass and becomes a controlled step that leaves a record.
This matters most for the documents patients act on. We cover where AI translation reaches submission accuracy for SmPC and patient leaflets under EMA rules, and which pharma documents suit AI translation with human review, because an informed consent form (ICF) and a summary of product characteristics (SmPC) carry more review than an internal status report.
Build the audit trail the EU AI Act expects
The audit trail is the deliverable buyers underrate. Under the EU AI Act (Regulation (EU) 2024/1689), Article 10 asks for data governance, Article 14 for human oversight, and Article 15 for accuracy, and an AI system used in a regulated process is expected to keep records of how output was produced and checked. A documented certified review gives you that record. An unlogged machine pass gives you nothing to show an inspector.
Clinical work adds its own rules. Under the Clinical Trials Regulation (Regulation (EU) 536/2014), consent and lay-summary documents sit in the trial master file with a 25-year retention expectation, and they often carry special-category health data under GDPR Article 9. Both reasons point the same way: keep the data on EU-hosted infrastructure, and keep the review on file. We rank providers on exactly that in best AI translation companies for pharma clinical trials.
Where it goes wrong
Four failure modes account for most of the migrations we're asked to rescue after the fact:
An unconstrained model. Run a general LLM with no term base and it will paraphrase a dosing instruction, invent synonyms for an endpoint, and produce fluent text that fails terminology review.
No human sign-off. Pushing raw output into the trial master file means no qualified person has taken responsibility for it, which is exactly what ISO 18587 and ICH E6(R3) require.
A public-cloud API. Sending consent forms or safety data through a public translation API moves special-category health data through servers you don't control, against GDPR Article 9 and your own data-residency rules.
Throwing away the legacy memory. The tuned engine you're leaving still holds years of approved wording. Migrate the translation memory, don't discard it, or you lose the sign-offs you already paid for.
We built our clinical workflow around those four traps. AD VERBUM runs trial documents on EU-hosted, client-tuned models with certified SME review, and you can see how we handle the regulated-document types in best AI translation services for pharmacovigilance and how we meet the clinical-record standard in does AI translation meet ICH E6(R3) for clinical trial documents.
Our clinical translation services
translation services for regulated sectors run on ISO 27001 and ISO 42001 certified, EU-hosted infrastructure, with no reliance on public cloud tooling for core processing. Every project runs through our AI+HUMAN hybrid translation workflow: we ingest client Translation Memories and Term Bases first, our proprietary LLM-based LangOps System generates output constrained by client terminology on client-tuned open-weight models, and our certified subject-matter experts review for technical accuracy and regulatory compliance. Our QA is aligned to ISO 17100 and ISO 18587, with sector-specific requirements such as ICH E6(R3) good clinical practice and the EU AI Act (Regulation 2024/1689) applied where relevant. We serve Life Sciences, Legal, Finance, Defense, and Manufacturing clients across 150+ languages with 3,500+ subject-matter linguists. For teams managing audit-sensitive content, contact us to discuss your security and compliance requirements directly.
FAQ
How do you move clinical translation to AI without failing an inspection?
Keep the record intact. No EMA or ICH rule names an AI translation tool, so an inspector checks whether your essential records are accurate and whether a qualified person signed for them under ICH E6(R3). Run a client-tuned model constrained by your term base, then certified ISO 18587 post-editing, and log the review in the trial master file.
Is AI translation accurate enough for informed consent forms?
Yes, with certified review. An informed consent form (ICF) carries high review demand because patients act on it, so AI translation here means constrained LLM output plus a named post-editor under ISO 18587 and ISO 17100. Raw machine output with no reviewer does not meet that bar.
Can we keep our legacy translation memory when we switch?
You should. The translation memory from your old engine holds years of approved wording and regulator-accepted terms. Migrate it into the new workflow so earlier sign-offs carry forward, rather than retranslating from scratch and losing that history.
Does AI clinical translation keep data inside the EU?
It does when you run an EU-hostable open-weight model on your own infrastructure, with no public-cloud API in the path and no training on client data. That keeps consent forms and safety data, which often count as special-category data under GDPR Article 9, under EU data residency.
What does the EU AI Act require for AI translation in trials?
Records and oversight. The EU AI Act (Regulation (EU) 2024/1689) expects data governance under Article 10, human oversight under Article 14, and accuracy under Article 15. For translation that means a documented certified review you can retrieve, not an unlogged machine pass.
Is raw machine translation the same as AI translation here?
No. Raw machine or NMT output with no review is not what we mean by AI translation. AD VERBUM's AI translation is a client-tuned LLM constrained by your term base, followed by certified human review under ISO 18587. That review is the difference, not a synonym.
